Gladstone in the News

The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.

The real culprit behind hardened arteries? Stem cells, says landmark study
June 6, 2012

Gladstone Cardiovascular Disease Research Director Dr. Deepak Srivastava is quoted in this report of a breakthrough finding from UC Berkeley.

 

Mission Bay Impresario Retires
May 25, 2012

Bruce Spaulding, one of the architects of San Francisco’s Mission Bay biotech enclave, is retiring for health reasons from the foundation supporting the Gladstone Institutes.

California Stem-cell Agency Shifts Toward Clinical Work
May 25, 2012

Deepak Srivastava, a cardiovascular researcher at the Gladstone Institute in San Francisco, was awarded a $6.3 million grant from the agency today, one of about twenty investigators to receive funds for translational programs.

Mission Bay casts wide net after Salesforce exit
May 25, 2012

When San Francisco-based Salesforce said in 2010 it was moving into Mission Bay, many in the life sciences community were disappointed that the medical and biotech enclave would be filled by high tech workers.

Reducing Brain Activity Aids Memory After Cognitive Decline
May 14, 2012

A study led by a Johns Hopkins neuroscientist and published in the May 10 issue of the journal Neuronsuggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer’s disease.

Super cells: The Gladstone Institutes Gala
May 13, 2012

Rare is the soiree that makes science sizzle. But that was the fact last week during the Gladstone Institutes Gala at the Four Seasons Hotel, where 450 guests were greeted by lab-coat-wearing waiters bearing test tubes filled with cocktails.

FDA panel recommends approval of drug to prevent HIV infection
May 10, 2012

For the first time in the 30-year battle against the HIV epidemic, a panel of experts has recommended that the Food and Drug Administration approve a drug to give to healthy people to protect against the infection.

HIV prevention pill Truvada backed by US experts
May 10, 2012

A panel of US health experts has for the first time backed a drug to prevent HIV infection in healthy people.

Gladstone's Dr. Robert M. Grant advises FDA on drug to prevent HIV infection risk
May 10, 2012

History was made Thursday evening as an FDA panel recommended approval of a drug that could prevent the spread of HIV, the virus that causes AIDS -- a disease that has killed 30 million people around the world.

Development of Nuclear Re-programming Technology for Generating Induced Pluripotent Stem Cells
May 10, 2012

Gladstone Institutes' Senior Investigator Dr. Shinya Yamanaka is profiled for his pioneering work in stem cell technology.